Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human TRAIL R3 (Extracellular Domain-2) | Login | Anti-Human TRAIL R3 (Extracellular Domain-2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R3 (Extracellular Domain-2) | Login | Anti-Human TRAIL R3 (Extracellular Domain-2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R4 (Internal Domain) | Login | Anti-Human TRAIL R4 (Internal Domain) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TRAIL R4 (Internal Domain) | Login | Anti-Human TRAIL R4 (Internal Domain) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Cetuximab) - Fc Muted™ - Custom | Login | Anti-Human EGFR (Cetuximab) - Fc Muted™ - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human EGFR (Cetuximab) - Custom | Login | Anti-Human EGFR (Cetuximab) - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human MyD88 (Intermediate Domain) | Login | Anti-Human MyD88 (Intermediate Domain) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human MyD88 (Intermediate Domain) | Login | Anti-Human MyD88 (Intermediate Domain) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD52 (Alemtuzumab) - Fc Muted™ - Custom | Login | Anti-Human CD52 (Alemtuzumab) - Fc Muted™ - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) (Mogamulizumab) - Fc Muted™ - Custom | Login | Anti-Human CD194 (CCR4) (Mogamulizumab) - Fc Muted™ - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Fc Muted™ - Custom | Login | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Fc Muted™ - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD194 (CCR4) (Mogamulizumab) - Custom | Login | Anti-Human CD194 (CCR4) (Mogamulizumab) - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNF alpha (Adalimumab) - Custom | Login | Anti-Human TNF alpha (Adalimumab) - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human TNF alpha (Adalimumab) - Fc Muted™ - Custom | Login | Anti-Human TNF alpha (Adalimumab) - Fc Muted™ - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD52 (Alemtuzumab) - Custom | Login | Anti-Human CD52 (Alemtuzumab) - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Custom | Login | Anti-Human CD49D (Integrin alpha 4) (Natalizumab) - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD38 (Daratumumab) | Login | Anti-Human CD38 (Daratumumab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD38 (Daratumumab) | Login | Anti-Human CD38 (Daratumumab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD38 (Daratumumab) | Login | Anti-Human CD38 (Daratumumab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HB-EGF (Clone 125923) - 500 µg | Login | Anti-Human HB-EGF (Clone 125923) - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human HGF - 500 µg | Login | Anti-Human HGF - 500 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse CD4 (Clone GK1.5) - PerCP - Custom | Login | Anti-Mouse CD4 (Clone GK1.5) - PerCP - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD45RO (Clone UCHL-1) - PerCP - Custom | Login | Anti-Human CD45RO (Clone UCHL-1) - PerCP - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD22 - PerCP - Custom | Login | Anti-Human CD22 - PerCP - Custom | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD19 - PerCP - Custom | Login | Anti-Human CD19 - PerCP - Custom | ||||||||||||||||
|
||||||||||||||||||


